LCM
ENZY

Laurion Capital Management’s Enzymotec Ltd ENZY Stock Holding History

Laurion Capital Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,732
Closed -$134K – 2029
2017
Q3 		$134K Sell
11,732
-49,181
-81% -$485K ﹤0.01% 1466
2017
Q2 		$493K Sell
60,913
-14,900
-20% -$124K ﹤0.01% 1267
2017
Q1 		$667K Sell
75,813
-34,100
-31% -$289K 0.01% 838
2016
Q4 		$720K Sell
109,913
-42,900
-28% -$282K 0.01% 768
2016
Q3 		$1.07M Sell
152,813
-35,187
-19% -$282K 0.01% 558
2016
Q2 		$1.57M Buy
+188,000
New +$1.56M 0.02% 425

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
CRA
Circle Road Advisors New York $27.7M AUM 35.85% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laurion Capital Management's ENZY Position: Q4 2017 in Review

Laurion Capital Management sold out of Enzymotec Ltd (ENZY) in Q4 2017, closing a stake of 11,732 shares — an estimated $134K sold.

Laurion Capital Management first reported a position in ENZY in Q2 2016 and held it in 6 quarters. The position peaked at $1.57M in Q2 2016. 37 funds tracked by Wall St. Rank hold ENZY as of Q4 2017.

  • Laurion Capital Management reported no remaining Enzymotec Ltd position as of Q4 2017 after selling out during the quarter.
  • Laurion Capital Management sold 11,732 Enzymotec Ltd shares in Q4 2017, an estimated $134K.
  • Laurion Capital Management first reported a position in Enzymotec Ltd in Q2 2016 and held it in 6 quarters.
  • Laurion Capital Management's Enzymotec Ltd position peaked at $1.57M in Q2 2016.
  • 37 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2017.

Based on Laurion Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.